Johan Burisch on the costs of inflammatory bowel disease in high-income settings
Release Date:
Johan Burisch (Copenhagen University Hospital, Denmark) discusses the findings and recommendations of The Lancet Gastroenterology & Hepatology Commission on the cost of inflammatory bowel disease in high-income settings.Read the Commission here:The cost of inflammatory bowel disease in high-income settingsContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
Johan Burisch on the costs of inflammatory bowel disease in high-income settings